Microtubule/Tubulin
Microtubule is the cylindrical and filamentous structure that required for cell shape, migration, cilia and flagella mobility etc. Tubulin is the major component of microtubules.
Products for Microtubule/Tubulin
- Cat.No. Product Name Information
- GC37900 Verubulin Verubulin (MPC-6827) is a microtubule-disrupting agent with potent and broad-spectrum in vitro and in vivo cytotoxic activities, and acts as a promising candidate for the treatment of multiple cancer types.
- GC12286 Vinblastine sulfate An inhibitor of microtubule assembly
- GC38410 Vincristine
- GC11511 Vincristine sulfate Microtubule disrupter,antitumor agent
- GC64451 Vincristine-d3-ester sulfate Vincristine-d3-ester (Leurocristine-d3-ester) sulfate is the deuterium labeled Vincristine sulfate. Vincristine sulfate is an antitumor vinca alkaloid which inhibits microtubule formation in mitotic spindle, resulting in an arrest of dividing cells at the metaphase stage. It binds to microtubule with a Ki of 85 nM.
- GC64915 Vindesine sulfate Vindesine sulfate is a potent tubulin inhibitor with an Ki of 0.110 ?M. Vindesine sulfate shows anti-proliferation effect in vitro. Vindesine sulfate shows antitumor effect in vivo.
- GC61584 Vinflunine ditartrate Vinflunine ditartrate is the first fluorinated microtubule inhibitor belonging to the Vinca alkaloids family. Vinflunine ditartrate has anti-angiogenic, vascular-disrupting and anti-metastatic activities. Vinflunine ditartrate can be used for the research of transitional cell carcinoma of the urothelial tract, non-small cell lung cancer, and carcinoma of the breast.
-
GC13815
Vinflunine Tartrate
Etanercept is an inhibitor of the inflammatory factor TNF-α and is mainly used for the clinical treatment of rheumatoid arthritis .
- GN10299 Vinorelbine
- GC14806 Vinorelbine ditartrate An inhibitor of microtubule polymerization
- GC18578 YK-3-237 An inhibitor of tubulin polymerization and activator of SIRT1
-
GC70163
Zagotenemab
Zagotenemab (LY3303560) is a humanized anti-tau antibody that selectively binds and neutralizes tau deposits in the brain. Zagotenemab can be used for research on Alzheimer's disease.